CannaRoyalty investee, Resolve Digital Health, to source cannabis for its Breeze Smart Inhalers from Aphria

Ottawa-based CannaRoyalty (CSE:CRZ) (OTCQX: CNNRF) investee, Resolve Digital Health, maker of the Breeze Smart Inhaler, announced an exclusive deal to source cannabis from Aphria (TSX: APHQF), one of Canada’s largest medical cannabis producers. Resolve will package the cannabis in its proprietary Breeze inhalers and market them globally.

Breeze Smart Inhalers provide metered, learned dosing and strain selection appropriate to a patient’s condition, continuously improving efficacy and patient experience.

Resolve will market its Breeze inhalers in Canada the USA and Australia.

On October 11, 2017, Resolve closed a deal giving Liberty Health Sciences exclusive distribution rights to market the inhalers in Florida. In summer 2017, Resolve signed a deal allowing the LeafCann Group to promote Breeze inhalers in Australia.

CannaRoyalty is an active investor and operator in the cannabis industry. It owns 27% of Resolve, worth roughly $7 million. Its stock traded between $1.500 – $3.800 over the last 52 weeks and closed at $2.90 today. Market cap is $122.07m, making it the roughly 50thlargest cannabis company by that measure.

Resolve markets its medical cannabis inhalers for the relief of symptoms from cancer, arthritis, migraines, and chronic pain. The inhalers are currently available in select pharmacies in the USA.

Aphria, with a market cap of $841.80m, is roughly the 7th largest cannabis company. Its stock closed today at $6.06.

Source: CannaRoyalty

CannaRoyalty investee, Resolve Digital Health, to source cannabis for its Breeze Smart Inhalers from Aphria

About Cannin.com: Your Marijuana Stocks Resource

Cannin is your #1 resource for marijuana stocks. Our global team of experts evaluates all emerging marijuana stock investing opportunities. We aggregate hundreds of hours of research and provide tips on the best marijuana stock investments for 2020.

Use Cannin as your resource for:

Is it too late to invest in marijuana stocks? No! This is the perfect time to invest.

Many market analysts expect the legal marijuana industry will have an annual value exceeding $75 Billion in the next decade. The time to invest in marijuana stocks is now.

Are you interested in marijuana stocks like Curaleaf, Trulieve, Aurora Cannabis, or Charlotte’s Web,?

Are you looking to buy stock in marijuana companies for 2020? Interested in emerging penny marijuana stocks? Looking for the best Canadian marijuana stocks to invest in? We can help.

Predict price movements of marijuana stocks several hours in advance with our proprietary algorithmic stock trading software.

+25% Gains in 2020
+49.8% Gains in 2019
108% Backtested since 2012

We’re so confident you’ll love our algotrading marijuana stock signals, we’re willing to give you a one-month risk-free trial to see it for yourself.

Profit from the best marijuana stocks – we’ll show you how at cannin.com.

Marijuana Stocks, Pot Stocks, Algorithmic Stock Trading, Best Hemp Stocks 2020

CannaRoyalty investee, Resolve Digital Health, to source cannabis for its Breeze Smart Inhalers from Aphria